Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pluri Inc
PLUR
Healthcare
Biotechnology
Pluri Inc., formerly known as Pluristem Therapeutics Inc., is an Israel-headquartered company engaged in the research and provision of cell-based products directed for a range of industries. The Company is focused on researching and developing cell transformation and 3D cell expansion technologies that allow mass production of cells. The products of the Company are used for the pharmaceutical...
industry as well as for food technology, agriculture technology, and cell-based materials. In the pharmaceutical sector, the Company's preclinical and clinical programs explore multiple therapeutic areas such as vascular disease, inflammation-related conditions, muscle injuries, and hematological disorders. In the food sector, the Firm produces cultivated meat, cultivated fish, and seafood, as well as plant-based products. In agriculture, the Company develops alternative farming methods. The Company has a portfolio of over 140 granted patents in approximately 52 countries.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:PLUR)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(76)
•••
lucaM1
X
Post by
lucaM1
on May 23, 2022 12:10pm
$PSTI vs S&P 500 YTD
$PSTI: -1% S&P 500: -17% $PSTI currently outperforming by 16%
(76)
•••
lucaM1
X
Post by
lucaM1
on May 17, 2022 10:06am
$PSTI company blog- Pluristem’s Cell-Based Technology Platf
Key global challenges in sustainable development Humans are the most populous large animal on earth today. In fact, the average global human population grows by 2.6 people every second (81
...more
(76)
•••
lucaM1
X
Post by
lucaM1
on May 15, 2022 9:42am
Benzinga Interview with Pluristem President and CEO
An interesting look into $PSTI and their new collaboration strategy https://www.youtube.com/watch?v=4bcHzVeRuTY&t=2s
(76)
•••
lucaM1
X
Post by
lucaM1
on May 09, 2022 9:25am
$PSTI among the 5 Biotech Penny Stocks Redditors Love
Pluristem Therapeutics Inc. (NASDAQ:PSTI) is a biotech firm specializing in cell therapeutic products and related technologies. In early January, the stock jumped more than 30% after the company
...more
(76)
•••
lucaM1
X
Post by
lucaM1
on May 03, 2022 9:06am
Cell and Gene Therapy Thawing Equipment Market report
Cell and Gene Therapy Thawing Equipment Market Research Report 2022 Cumulative Impact of COVID-19 Top companies in the market: Pluristem Therapeutics, Genesis BPS, Eppendorf, Cytiva (A subsidiary
...more
(76)
•••
lucaM1
X
Post by
lucaM1
on May 01, 2022 9:53am
Cultured meat proof of concept in May?
The cultured meat proof of concept is expected to be published in Q2. Big chance it happens this month. The stock could really benefit and see and significant rise.
(76)
•••
lucaM1
X
Post by
lucaM1
on Apr 26, 2022 10:21am
Pluristem therapeutics ($PSTI) stock analysis
https://www.youtube.com/watch?v=aiAVqrdQ4EI&t=136s
(76)
•••
lucaM1
X
Post by
lucaM1
on Apr 24, 2022 9:58am
Israeli Companies Want to Bring Lab-grown Meat to the Masses
An Israeli biotech company and food giant Tnuva rang the bell at NASDAQ March 28, celebrating their partnership to produce lab-grown meat. Pluristem Therapeutics and Tnuva joined the race to create
...more
(76)
•••
lucaM1
X
Post by
lucaM1
on Apr 17, 2022 10:53am
A New Cultured Meat report
A New Cultured Meat report was released by visualcapitalist.com. The report, in part, talks about the big financial potential of this up-and-coming industry: "Depending on
...more
(76)
•••
lucaM1
X
Post by
lucaM1
on Apr 17, 2022 10:45am
New Cultured Meat Report
A New Cultured Meat report was released by visualcapitalist.com. The report, in part, talks about the big finincial potentcial of this upandconing industry: "Depending on factors such
...more
(76)
•••
lucaM1
X
Post by
lucaM1
on Apr 14, 2022 10:54am
Yahoo Finance on $PSTI:
Pluristem Therapeutics Inc. (NASDAQ:PSTI) is an Israel-based biotechnology company that works to develop and research cell therapeutic products for the treatment of ischemic, inflammatory, and
...more
(76)
•••
lucaM1
X
Post by
lucaM1
on Apr 11, 2022 10:29am
Cell and Gene Therapy to Witness Huge
Cell and Gene Therapy Thawing Equipment Market to Witness Huge Growth by 2029 | Pluristem Therapeutics Inc among the leaders in the market https://www.bloomingprairieonline.com/cell-and-gene-therapy
...more
(76)
•••
lucaM1
X
Post by
lucaM1
on Apr 07, 2022 5:01pm
Insider Monkey On $PSTI
Pluristem Therapeutics Inc. (NASDAQ:PSTI) Number of Hedge Fund Holders: 4 Share Price as of April 5: $2.11 Pluristem Therapeutics Inc. (NASDAQ:PSTI) is an Israel-based biotechnology
...more
(76)
•••
lucaM1
X
Post by
lucaM1
on Apr 04, 2022 11:54am
Cell Expansion Market To Reach Value Of USD 39.74 Billion
The global cell expansion market is estimated to reach value of USD 39.74 Billion by 2027, according to a current analysis by Emergen Research. Cell expansion is witnessing a surge
...more
(76)
•••
lucaM1
X
Post by
lucaM1
on Mar 31, 2022 10:03am
PSTI could provide the first ever kosher meat product
PSTI could provide the first ever kosher meat product. The PSTI CEO said they have had discussions with rabbis and are expecting the product to be certified as kosher and pareve — that is, neither
...more
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.